You just read:

Two Studies Reveal Differences In Real-World Treatment Patterns In Rheumatoid Arthritis Patients Taking REMICADE® (infliximab) Compared To CT-P13 (infliximab biosimilar)

News provided by

Janssen Biotech, Inc.

14 Nov, 2016, 08:00 ET